Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy
2020 · Biomedicine & Pharmacotherapy · 31 citations
https://doi.org/10.1016/j.biopha.2020.110457
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
240
Citations
4
h-index
3
i10-index
Shoujian Ji is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Esophageal Cancer Research and Treatment & Pancreatic and Hepatic Oncology Research. The author has an h-index of 4, co-authored 8 publications.
Click to start Chat